$UGRO
urban-gro, Inc. Stock $ugro

$ugro Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000170652423000041 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$18.84M	$16.77M	$21.05M
YoY Change	15.7%	-20.37%	74.94%
Cost Of Revenue	$15.96M	$13.92M	$16.15M
YoY Change	24.91%	-13.79%	71.93%
Gross Profit	$2.875M	$2.842M	$4.902M
YoY Change	-17.91%	-42.03%	85.64%
Gross Profit Margin	15.26%	16.95%	23.28%
Selling, General & Admin	$6.497M	$7.579M	$5.770M
YoY Change	26.83%	31.35%	131.92%
% of Gross Profit	226.01%	266.68%	117.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$160.0K	$94.05K	$218.3K
YoY Change	-56.94%	-56.91%	291.96%
% of Gross Profit	5.57%	3.31%	4.45%
Operating Expenses	$6.761M	$7.889M	$5.770M
YoY Change	24.54%	36.72%	131.92%
Operating Profit	-$3.886M	-$5.047M	-$867.8K
YoY Change	101.69%	481.56%	-667.81%
Interest Expense	$30.07K	-$90.00	$72.19K
YoY Change	-24.1%	-100.12%	-107.57%
% of Operating Profit
Other Income/Expense, Net	-$1.611M	-$163.1K	-$8.690K
YoY Change	-1548.89%	1776.99%	-407.07%
Pretax Income	-$5.497M	-$5.210M	-$804.3K
YoY Change	202.76%	547.76%	-49.37%
Income Tax	-$53.97K	-$65.13K	-$108.1K
% Of Pretax Income
Net Earnings	-$5.443M	-$5.145M	-$696.2K
YoY Change	212.96%	638.94%	-56.17%
Net Earnings / Revenue	-28.9%	-30.69%	-3.31%
Basic Earnings Per Share	-$0.50	-$0.48	-$0.07
Diluted Earnings Per Share	-$0.50	-$0.48	-$66.25K
COMMON SHARES
Basic Shares Outstanding	10.94M shares	10.77M shares	10.51M shares
Diluted Shares Outstanding	10.95M shares	10.77M shares	10.51M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.559M	$7.327M	$27.05M
YoY Change	-62.41%	-72.91%	-45.81%
Cash & Equivalents	$8.559M	$7.327M	$27.05M
Short-Term Investments
Other Short-Term Assets	$39.82K	$38.77K	$10.08M
YoY Change	23.72%	-99.62%	161.59%
Inventory	$300.5K	$329.5K	$354.3K
Prepaid Expenses	$885.4K	$1.106M
Receivables	$15.48M	$22.07M	$13.47M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$34.52M	$36.90M	$50.96M
YoY Change	-22.86%	-27.58%	-7.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.333M	$1.367M	$901.2K
YoY Change	54.27%	51.67%	453.47%
Goodwill	$15.57M	$15.57M
YoY Change	46.4%
Intangibles	$4.877M	$5.141M
YoY Change	-0.21%
Long-Term Investments	$2.585M	$2.572M	$4.210M
YoY Change	-38.6%	-38.91%	146.17%
Other Assets
YoY Change
Total Long-Term Assets	$26.76M	$27.19M	$14.52M
YoY Change	25.61%	87.33%	407.65%
TOTAL ASSETS
Total Short-Term Assets	$34.52M	$36.90M	$50.96M
Total Long-Term Assets	$26.76M	$27.19M	$14.52M
Total Assets	$61.29M	$64.09M	$65.47M
YoY Change	-7.23%	-2.1%	12.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.55M	$14.87M	$7.931M
YoY Change	133.48%	87.44%	255.53%
Accrued Expenses	$5.183M	$5.215M	$3.327M
YoY Change	53.3%	56.77%	125.89%
Deferred Revenue	$1.940M	$2.356M
YoY Change	-40.95%
Short-Term Debt	$1.941M	$2.908M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$31.82M	$30.90M	$20.06M
YoY Change	75.01%	54.08%	112.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.823M	$1.965M	$474.9K
YoY Change	326.05%	313.76%
Total Long-Term Liabilities	$2.737M	$2.933M	$474.9K
YoY Change	68.02%	517.65%
TOTAL LIABILITIES
Total Short-Term Liabilities	$31.82M	$30.90M	$20.06M
Total Long-Term Liabilities	$2.737M	$2.933M	$474.9K
Total Liabilities	$34.56M	$33.84M	$20.86M
YoY Change	74.43%	62.18%	120.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.71M	-$43.26M
YoY Change	92.7%
Common Stock	$13.06K	$12.39K
YoY Change	9.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$12.05M	$12.05M
YoY Change	5.14%
Treasury Stock Shares
Shareholders Equity	$26.73M	$30.26M	$44.61M
YoY Change
Total Liabilities & Shareholders Equity	$61.29M	$64.09M	$65.47M
YoY Change	-7.23%	-2.1%	12.83%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$5.443M	-$5.145M	-$696.2K
YoY Change	212.96%	638.94%	-56.17%
Depreciation, Depletion And Amortization	$160.0K	$94.05K	$218.3K
YoY Change	-56.94%	-56.91%	291.96%
Cash From Operating Activities	$3.615M	-$4.273M	-$3.727M
YoY Change	-401.95%	14.64%	-1348.75%
INVESTING ACTIVITIES
Capital Expenditures	$92.87K	$133.8K	-$32.34K
YoY Change	-127.13%	-513.83%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$92.87K	-$133.8K	-$32.34K
YoY Change	-96.96%	313.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.290M	-$273.7K	-3.780M
YoY Change	6262.03%	-92.76%	-107.65%
NET CHANGE
Cash From Operating Activities	3.615M	-$4.273M	-3.727M
Cash From Investing Activities	-92.87K	-$133.8K	-32.34K
Cash From Financing Activities	-2.290M	-$273.7K	-3.780M
Net Change In Cash	1.232M	-$4.681M	-7.540M
YoY Change	-128.75%	-37.92%
FREE CASH FLOW
Cash From Operating Activities	$3.615M	-$4.273M	-$3.727M
Capital Expenditures	$92.87K	$133.8K	-$32.34K
Free Cash Flow	$3.522M	-$4.407M	-$3.695M
YoY Change	-511.99%	19.27%	-1337.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001706524
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39933
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	URBAN-GRO, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-5158469
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1751 Panorama Point
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Unit G
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Lafayette
CY2022Q4	us-gaap	Goodwill Goodwill	15572050	usd
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80026
CY2023Q1	dei	City Area Code CityAreaCode	720
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	390-3880
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2023Q1	dei	Trading Symbol TradingSymbol	UGRO
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10938556	shares
CY2023Q1	us-gaap	Cash Cash	7327485	usd
CY2022Q4	us-gaap	Cash Cash	12008003	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22069269	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15380292	usd
CY2023Q1	us-gaap	Billed Contract Receivables BilledContractReceivables	2817407	usd
CY2022Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	3004282	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4685529	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4164960	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	36899690	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	34557537	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1366761	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1307146	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2542644	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2618825	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	2572103	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	2559307	usd
CY2023Q1	us-gaap	Goodwill Goodwill	15572050	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5140667	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5450687	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	27194225	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	27508015	usd
CY2023Q1	us-gaap	Assets Assets	64093915	usd
CY2022Q4	us-gaap	Assets Assets	62065552	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	14865846	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9960364	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5215255	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3196961	usd
CY2023Q1	ugro	Contract Liabilities Current ContractLiabilitiesCurrent	2413423	usd
CY2022Q4	ugro	Contract Liabilities Current ContractLiabilitiesCurrent	1294452	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2355609	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2571161	usd
CY2023Q1	ugro	Contingent Consideration Current ContingentConsiderationCurrent	2537291	usd
CY2022Q4	ugro	Contingent Consideration Current ContingentConsiderationCurrent	2799287	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2908213	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3832682	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	606648	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	600816	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	30902285	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24255723	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1964804	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2044782	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	968151	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1033283	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2932955	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3078065	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12388389	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10938556	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	12220593	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10770760	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	12388	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	12221	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	85554375	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	84882982	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1449833	shares
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1449833	shares
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	12045542	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	12045542	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43262546	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38117897	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	30258675	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34731764	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64093915	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	62065552	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21052869	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	13923537	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16150849	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	2841848	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	4902020	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7098858	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4725301	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	479641	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	882000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	310020	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	162500	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	7888519	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	5769801	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5046671	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-867781	usd
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	73216	usd
CY2022Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	7658	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	73131	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	79852	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	160232	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2793	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-8690	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-163110	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	63504	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5209781	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-804277	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-65132	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-108060	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5144649	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-696217	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5144649	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-696217	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10772705	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10772705	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10508972	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10508972	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34731764	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	479641	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	191919	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5144649	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	30258675	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	48167330	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	882000	usd
CY2022Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3773177	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	28797	usd
CY2022Q1	ugro	Stock Issued In Conversion Of Warrants Value StockIssuedInConversionOfWarrantsValue	0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-696217	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	44608733	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5144649	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-696217	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	404069	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	218278	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-65132	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-108060	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	479641	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	882000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	160232	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-327189	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	56921	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6827927	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	354181	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	334525	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1439679	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7118280	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1092601	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-174592	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-33913	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-215552	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6110537	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4272966	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3727271	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	133833	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	32336	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133833	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32336	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	28797	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3773177	usd
CY2023Q1	ugro	Finance Lease Payments FinanceLeasePayments	43410	usd
CY2022Q1	ugro	Finance Lease Payments FinanceLeasePayments	36000	usd
CY2023Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	230309	usd
CY2022Q1	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-273719	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3780380	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4680518	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7539987	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12008003	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	34592190	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7327485	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	27052203	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	6475	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	7658	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	23487	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	55120	usd
CY2023Q1	ugro	Operating Lease Right Of Use Assets And Liabilities Extension OperatingLeaseRightOfUseAssetsAndLiabilitiesExtension	101264	usd
CY2022Q1	ugro	Operating Lease Right Of Use Assets And Liabilities Extension OperatingLeaseRightOfUseAssetsAndLiabilitiesExtension	0	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2908213	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3832682	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing condensed consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of assets and liabilities at the date of the condensed consolidated financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include estimated revenues earned under construction design-build contracts; estimated useful lives and potential impairment of long-lived assets, intangibles and goodwill; inventory write-offs; allowance for deferred tax assets; and allowance for bad debt.</span></div>
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reclassification</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Balance Sheet Classifications</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes in current assets and liabilities the following amounts that are in connection with construction contracts that may extend beyond one year: contract assets and contract liabilities (including retainage invoiced to customers contingent upon anything other than the passage of time), capitalized costs to fulfill contracts, retainage payable to sub-contractors and accrued losses on uncompleted contracts. A one-year time period is used to classify all other current assets and liabilities when not otherwise prescribed by the applicable accounting principles.</span></div>
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16765385	usd
CY2023Q1	ugro	Revenue From Contract With Customer Excluding Assessed Tax Relative Percent RevenueFromContractWithCustomerExcludingAssessedTaxRelativePercent	1
CY2023Q1	ugro	Revenue From Contract With Customer Excluding Assessed Tax Relative Percent RevenueFromContractWithCustomerExcludingAssessedTaxRelativePercent	1
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21052869	usd
CY2022Q1	ugro	Revenue From Contract With Customer Excluding Assessed Tax Relative Percent RevenueFromContractWithCustomerExcludingAssessedTaxRelativePercent	1
CY2022Q1	ugro	Revenue From Contract With Customer Excluding Assessed Tax Relative Percent RevenueFromContractWithCustomerExcludingAssessedTaxRelativePercent	1
CY2023Q1	ugro	Revenue Recognized In Excess Of Amounts Paid Or Payable Contract Receivables To The Company On Uncompleted Contracts Contract Asset Excluding Retainage RevenueRecognizedInExcessOfAmountsPaidOrPayableContractReceivablesToTheCompanyOnUncompletedContractsContractAssetExcludingRetainage	2795428	usd
CY2022Q4	ugro	Revenue Recognized In Excess Of Amounts Paid Or Payable Contract Receivables To The Company On Uncompleted Contracts Contract Asset Excluding Retainage RevenueRecognizedInExcessOfAmountsPaidOrPayableContractReceivablesToTheCompanyOnUncompletedContractsContractAssetExcludingRetainage	2874141	usd
CY2023Q1	ugro	Retainage Included In Contract Assets Due To Being Conditional On Something Other Than Solely Passage Of Time RetainageIncludedInContractAssetsDueToBeingConditionalOnSomethingOtherThanSolelyPassageOfTime	21979	usd
CY2022Q4	ugro	Retainage Included In Contract Assets Due To Being Conditional On Something Other Than Solely Passage Of Time RetainageIncludedInContractAssetsDueToBeingConditionalOnSomethingOtherThanSolelyPassageOfTime	130141	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2817407	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	3004282	usd
CY2023Q1	ugro	Payments Received Or Receivable Contract Receivables In Excess Of Revenue Recognized On Uncompleted Contracts Contract Liability Excluding Retainage PaymentsReceivedOrReceivableContractReceivablesInExcessOfRevenueRecognizedOnUncompletedContractsContractLiabilityExcludingRetainage	2197355	usd
CY2022Q4	ugro	Payments Received Or Receivable Contract Receivables In Excess Of Revenue Recognized On Uncompleted Contracts Contract Liability Excluding Retainage PaymentsReceivedOrReceivableContractReceivablesInExcessOfRevenueRecognizedOnUncompletedContractsContractLiabilityExcludingRetainage	1294452	usd
CY2023Q1	ugro	Contract With Customer Liability Including Retainage ContractWithCustomerLiabilityIncludingRetainage	216068	usd
CY2022Q4	ugro	Contract With Customer Liability Including Retainage ContractWithCustomerLiabilityIncludingRetainage	0	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2413423	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1294452	usd
CY2023Q1	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss Current ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent	21069269	usd
CY2022Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss Current ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent	12466180	usd
CY2023Q1	us-gaap	Nontrade Receivables NontradeReceivables	1000000	usd
CY2022Q4	us-gaap	Nontrade Receivables NontradeReceivables	2914112	usd
CY2022Q4	ugro	Miscellaneous Nontrade Receivable MiscellaneousNontradeReceivable	514112	usd
CY2022Q4	ugro	Legal Settlement Receivable LegalSettlementReceivable	2400000	usd
CY2023Q1	us-gaap	Proceeds From Legal Settlements ProceedsFromLegalSettlements	2400000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	15572050	usd
CY2023Q1	ugro	Vendor Prepayments Current VendorPrepaymentsCurrent	3211513	usd
CY2022Q4	ugro	Vendor Prepayments Current VendorPrepaymentsCurrent	2459389	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1105792	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1346430	usd
CY2023Q1	ugro	Prepaid Inventory Current PrepaidInventoryCurrent	329455	usd
CY2022Q4	ugro	Prepaid Inventory Current PrepaidInventoryCurrent	320372	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	38769	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	38769	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4685529	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4164960	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	745664	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	667269	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1366761	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1307146	usd
CY2023Q1	us-gaap	Depreciation Depreciation	94049	usd
CY2022Q1	us-gaap	Depreciation Depreciation	55778	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	2559307	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount	12796	usd
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	2572103	usd
CY2022Q4	us-gaap	Goodwill Goodwill	15572050	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6758213	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1645837	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5112376	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	28291	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	28291	usd
CY2023Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	6786504	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1645837	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5140667	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	6758213	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1335817	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5422396	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	28291	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	28291	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	6786504	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1335817	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5450687	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	310020	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	162500	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	756005	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	959788	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	959788	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	918205	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	693555	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	825035	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5112376	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1520517	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	515858	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1697058	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	639614	usd
CY2023Q1	us-gaap	Other Employee Related Liabilities Current And Noncurrent OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent	95732	usd
CY2022Q4	us-gaap	Other Employee Related Liabilities Current And Noncurrent OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent	262599	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1901948	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	1778890	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5215255	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3196961	usd
CY2023Q1	ugro	Lessee Operating Lease Number Of Leases LesseeOperatingLeaseNumberOfLeases	7	lease
CY2023Q1	ugro	Lessee Finance Lease Number Of Leases LesseeFinanceLeaseNumberOfLeases	1	lease
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.080
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.080
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2571452	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2645598	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	606648	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	600816	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1964804	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2044782	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	858972	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	750076	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	573133	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	404751	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	346812	usd
CY2023Q1	ugro	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	335903	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3269647	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	698195	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2571452	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	479641	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	882000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	669388	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y10M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.77
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	ugro	Share Based Compensation Arrangement By Share Based Payment Award Options Issued Weighted Average Remaining Contractual Term1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm1	P0Y
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	2803	shares
CY2023Q1	ugro	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm	P0Y
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	9.39
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q1	ugro	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm	P0Y
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	666585	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.77
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	618651	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y6M
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.30
CY2023Q1	ugro	Share Based Compensation Arrangement By Share Based Payment Award Options Vesting In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestingInPeriod	47934	shares
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	164562	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2021Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	usd
CY2021Q2	us-gaap	Stock Repurchase Program Period In Force1 StockRepurchaseProgramPeriodInForce1	P12M
CY2022Q1	ugro	Stock Repurchase Program Increase To Authorized Amount StockRepurchaseProgramIncreaseToAuthorizedAmount	2000000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	7000000	usd
CY2022Q1	ugro	Stock Repurchase Program Increase To Authorized Amount StockRepurchaseProgramIncreaseToAuthorizedAmount	1500000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	8500000	usd
CY2022Q3	ugro	Stock Repurchase Program Increase To Authorized Amount StockRepurchaseProgramIncreaseToAuthorizedAmount	2000000	usd
CY2022Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10500000	usd
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1099833	shares
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	8.25
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9100000	usd
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	419088	shares
CY2022Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	9.02
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3800000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	1400000	usd
CY2021Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	350000	shares
CY2021Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	8.50
CY2021Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3000000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	311499	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	12.32
CY2023Q1	ugro	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0	shares
CY2023Q1	ugro	Class Of Warrant Or Right Exercised Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisedExercisePriceOfWarrantsOrRights	0
CY2023Q1	ugro	Class Of Warrant Or Right Terminated Cashless Exercise ClassOfWarrantOrRightTerminatedCashlessExercise	0	shares
CY2023Q1	ugro	Class Of Warrant Or Right Terminated Cashless Exercise Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightTerminatedCashlessExerciseExercisePriceOfWarrantsOrRights	0
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	311499	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	12.32
CY2023Q1	ugro	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	311499	shares
CY2023Q1	ugro	Class Of Warrant Or Right Excisable Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExcisableExercisePriceOfWarrantsOrRights	12.32
CY2023Q1	ugro	Class Of Warrant Or Right Weighted Average Life ClassOfWarrantOrRightWeightedAverageLife	P1Y7M6D
CY2023Q1	ugro	Class Of Warrant Or Right Outstanding Intrinsic Value ClassOfWarrantOrRightOutstandingIntrinsicValue	0	usd
CY2023Q1	ugro	Class Of Warrant Or Right Exercisable Intrinsic Value ClassOfWarrantOrRightExercisableIntrinsicValue	0	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001706524-23-000041-index-headers.html	Edgar Link	pending
0001706524-23-000041-index.html	Edgar Link	pending
0001706524-23-000041.txt	Edgar Link	pending
0001706524-23-000041-xbrl.zip	Edgar Link	pending
a033123-exx311.htm	Edgar Link	pending
a033123-exx312.htm	Edgar Link	pending
a033123-exx321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ugro-20230331.htm	Edgar Link	pending
ugro-20230331.xsd	Edgar Link	pending
ugro-20230331_cal.xml	Edgar Link	unprocessable
ugro-20230331_def.xml	Edgar Link	unprocessable
ugro-20230331_lab.xml	Edgar Link	unprocessable
ugro-20230331_pre.xml	Edgar Link	unprocessable
ugro-20230331_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UGRO
urban-gro, Inc. Stock $ugro

2023 Q2 Form 10-Q Financial Statement

#000170652423000041 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UGRO urban-gro, Inc. Stock $ugro

2023 Q2 Form 10-Q Financial Statement

#000170652423000041 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UGRO
urban-gro, Inc. Stock $ugro